Risk of a second cancer after childhood cancer — what every survivor's family needs to know

What is a second cancer after childhood cancer?

A second cancer after childhood cancer — also called a secondary malignancy, second primary cancer, or treatment-related cancer — is a new, separate cancer that develops in a childhood cancer survivor. It is not the same cancer returning (that would be a relapse). It is a distinct new cancer, usually arising years or even decades after the original treatment ended.

This distinction matters because the cause, the location, and the treatment approach for a second cancer can be entirely different from those of the first cancer. It also means that the risk does not disappear after a few "all-clear" check-ups — it persists for many years, which is why long-term follow-up in a specialist survivorship programme is so important.

Most childhood cancer survivors will never develop a second malignancy. The risk is real but uncommon — and knowing about it allows families to stay appropriately alert and attend the follow-up visits that give the best chance of early detection if something does arise.

Why does it happen? Some cancer treatments — particularly high-dose radiation and certain chemotherapy agents — can cause lasting changes in the DNA of healthy cells. Over many years, some of those changes may accumulate and lead to a new cancer. Additionally, children with a hereditary cancer predisposition (for example, those whose retinoblastoma was caused by an inherited gene variant) carry an elevated baseline risk of certain other cancers throughout their lifetime, independent of the treatment they received.

How long after treatment can it appear? There is no fixed answer. Treatment-related leukaemias, linked to certain chemotherapy agents, most often appear within the first five to ten years after treatment. Solid tumours in previously irradiated areas can appear much later — sometimes twenty or more years after the original cancer was treated. This is another reason why follow-up should not stop after five years.

Related: Paediatric Cancer Overview  ·  Late Effects of Childhood Cancer Treatment  ·  Childhood Cancer Survival Rates

Which treatments raise the risk — and how?

Every treatment used in childhood cancer carries a risk-benefit balance. The treatments below are associated with a modestly higher long-term risk of a second malignancy. Knowing what your child received helps the team plan the right surveillance.

Warning signs of a second cancer in a childhood cancer survivor

None of these symptoms automatically means a second cancer — most will have a far more ordinary explanation. But as a parent of a secondary cancer survivor, you deserve to know what is worth reporting to your child's follow-up team, rather than waiting.

1. 01

   A new lump or swelling that does not go away

   Any new, painless lump — particularly in the neck, armpit, groin, or at the site of previous radiation — that persists beyond two to three weeks without a clear infectious cause is worth reporting. This includes swollen lymph nodes that keep growing rather than returning to normal after an infection resolves. Most lumps in children and young adults are benign, but a specialist evaluation provides certainty.

2. 02

   Unexplained fatigue or pallor

   Unusual tiredness that is not explained by activity level, illness, or growth, especially when accompanied by pallor (pale skin, pale gums, or pale inner eyelids), can sometimes signal a problem with the bone marrow. Survivors who received treatments known to affect the bone marrow — or who have not had a recent blood count — should have this investigated promptly.

3. 03

   Unusual bruising or bleeding without injury

   Bruises appearing without any known bump, or bleeding from the gums and nose that is more frequent or harder to stop than usual, can be a sign that platelet counts are lower than they should be. This pattern is familiar to families who went through treatment for leukaemia the first time — it is worth acting on quickly rather than watching and waiting.

4. 04

   Persistent bone or joint pain

   Deep bone pain that wakes your child at night, or pain in a limb that cannot be explained by sports or injury, is worth taking seriously — particularly in survivors who had radiation to a limb or who had bone sarcoma as their first cancer. Bone pain from a second malignancy in a child is often mistaken for growing pains. A straightforward X-ray and blood test can help clarify the picture quickly.

5. 05

   Thyroid changes or a neck lump

   Children who received radiation that included the neck area have a higher lifetime risk of thyroid cancer and thyroid dysfunction compared to the general population. A new nodule felt in the front of the neck, or changes in energy and weight not explained by other causes, should prompt a thyroid check. Thyroid cancer — when detected early — is among the most treatable of all cancers.

What long-term follow-up looks like — and why it matters

Long-term follow-up for a childhood cancer survivor is not a single visit. It is a structured, evolving programme that adapts as your child grows — and it is built around what was actually used in their treatment, not a generic checklist.

Review of the treatment summary. The starting point is a detailed review of every treatment your child received — radiation fields and doses, chemotherapy agents and cumulative doses, any surgery. This record becomes the foundation for understanding which specific late effects and second malignancies your child needs to be watched for.

Scheduled monitoring. Depending on the treatment history, follow-up may include regular blood counts, thyroid function tests, cardiac assessments, bone density monitoring, and — for those who received chest radiation — consideration of earlier-than-usual breast imaging when appropriate. The schedule is tailored, written down, and shared with your family doctor so that nothing falls through the gap when your child transitions to adult care.

Genetic counselling where indicated. For children whose first cancer was associated with an inherited predisposition syndrome, a genetics consultation is recommended. Understanding the inherited risk helps the whole family — siblings, parents, and your child themselves as they move into adulthood — make informed decisions about their own health.

Lifestyle guidance. While the treatment-related risk cannot be reversed, certain habits meaningfully reduce the overall cancer risk for any person. Avoiding tobacco completely, maintaining a healthy weight, eating a varied diet with plenty of vegetables and fibre, protecting skin that was irradiated from excessive sun exposure, and limiting alcohol intake as your child grows into adulthood — these are practical, evidence-based steps that every survivor can take.

Continuity into adulthood. Paediatric oncology teams typically care for children through their teenage years and into early adulthood. Planning the transition to adult oncology services carefully — with a written summary handed over, and a named adult specialist who understands childhood cancer late effects — ensures that surveillance does not lapse during a period when young adults are busy with education, careers, and new relationships.

At CION, our team includes specialists who understand the full span of childhood cancer survivorship. Every survivor's care is discussed by a tumour board — not a single doctor's opinion. You deserve a plan that is thorough, honest, and built around your child's actual history. Decisions for healing, not billing.

You walked through treatment once. Let us help protect what comes next.

A 45-minute consultation with our paediatric survivorship team. No rushed decisions. A written plan you can take home. Completely free for the first appointment.

This page provides general educational information. It is not a substitute for personalised medical advice. Please consult your child's oncology team about their specific history and follow-up needs.